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ABSTRACT 
 
 
 Nucleoli are nuclear membrane-less organelles that are the sites for ribosome 
biogenesis and serve as sensors of cellular stress. Weak, multivalent protein-protein 
interactions and interactions between disordered, low complexity domains (LCDs) and 
rRNA have been shown to promote liquid-liquid phase separation (LLPS) in vitro, 
suggesting a basis for the liquid-like behavior of nucleoli. Nucleophosmin (NPM1), a 
multifunctional and highly abundant nucleolar protein, exhibits structural features 
associated with LLPS suggesting a role in nucleolar organization. Specifically, NPM1 
forms a pentamer through its N-terminal oligomerization domain and can bind to rRNA 
through its C-terminal nucleic acid binding domain. Multiple acidic tracts throughout 
NPM1, two within an intrinsically disordered region (IDR), confer additional 
multivalency and mediate interactions with proteins that contain multiple arginine-rich 
motifs (R-proteins). Using a variety of techniques, we have identified several nucleolar 
R-proteins which bind to and phase separate with NPM1. Here we show that the liquid-
like properties of NPM1 droplets can be tuned by modulating the extent of electrostatic 
interactions within the droplet. We propose that a hierarchy of R-motifs, varying in 
valency and affinity, within nucleolar R-proteins exists which leads to a heterogeneous 
network of interactions between proteins and rRNA within nucleoli, thus promoting 
formation of a dynamic liquid-like phase conducive to ribosome biogenesis and other 
nucleolar functions.  
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CHAPTER 1.    INTRODUCTION 
 
 
Eukaryotic organisms harbor various organelles to separate macromolecules and 
enzymatic reactions within cells. These organelles are separated into two classes: 
membrane-bound, and membrane-less. Membrane-bound (e.g. mitochondria, nuclei, and 
the endoplasmic reticulum) are encapsulated in a lipid bilayer, which enables these 
organelles to maintain their localization of proteins, nucleic acids, and other 
biomolecules. The assembly, function, and maintenance of membrane-bound organelles 
has been studied extensively for years and is now better understood. In contrast, 
understanding of membrane-less organelles is currently limited. Yet, over the last few 
years a new field of science has emerged to close this gap, which focuses to understand 
the physical basis for the formation of membrane-less organelles, and how their 
components and biophysical properties are related to their structure and function.  
 
 
Membrane-Less Organelles 
 
Membrane-less organelles such as stress granules, Cajal bodies, and nucleoli, 
arise through reversible self-assembly of soluble proteins and nucleic acids (Burke, et. al., 
2015; Guo, et. al., 2015; Nott, et. al., 2015; Weber and Brangwynne, 2012; Zhang, et. al., 
2015). Additionally, many have been shown to behave like liquids in that they are 
spherical in nature, can fuse with like organelles, and their components are highly 
dynamic and can exchange with components outside of the organelle (Elbaum-Garfinkle, 
et. al., 2015; Molliex, et. al., 2015; Nott, et. al., 2015; Zhang, et. al., 2015). Furthermore, 
it has been suggested that the formation of these organelles occurs through phase 
separation of molecular components (Molliex, et. al., 2015; Weber and Brangwynne, 
2015; Patel, et. al., 2015). As these organelles do not have a lipid membrane to separate 
their components from the nucleo- or cytoplasm, membrane-less organelles are able to 
respond to changes in the environment (Mitrea and Kriwacki, 2016). This characteristic 
may be the basis for why many membrane-less organelles are known to play a role in cell 
stress responses (Boisvert, et. al., 2007; Buchan, 2014; Cioce and Lamond, 2005; Fox 
and Lamond, 2010). 
 
 
P Granules 
 
The specific type of germ granules (i.e., the class of granules which dictate germ-
cell specification) termed P granules are cytoplasmic ribonucleoprotein complexes found 
within Caenorhabditis elegans (Brangwynne, et. al., 2009; Schneider and Bowerman, 
2003). Initially, P granules are distributed evenly throughout the one-cell embryo, 
however, once the cell prepares for meiotic division and becomes polarized, P granules 
become localized to the posterior half of the cell (Brangwynne, et. al., 2009). 
Asymmetrical localization and division allows for the maintenance of P granule positive 
progenitor cells and the creation of a P granule negative somatic sister cell (Brangwynne, 
et. al., 2009). This asymmetric localization of P granules has been shown to be due to 
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changes in local protein concentrations leading to dissolution and assembly of granules, 
respectively, in the different cellular locations rather than migration of P granules to one 
side of the cell (Brangwynne, et. al., 2009). This observation is what first led the field to 
propose a mechanism where membrane-less organelles are formed by liquid-liquid phase 
separation (LLPS) of their components. Further supporting this hypothesis, when mixed 
in vitro, the disordered P granule protein, LAF-1, and RNA phase separate to form liquid-
like droplets (Elbaum-Garfinkle, et. al., 2015). Many groups subsequently found that 
disordered proteins and often RNA are critical for in vivo and in vitro LLPS (Weber and 
Brangwynne, 2012; Feric, et. al., 2016; Mitrea, et. al., 2016; Molliex, et. al., 2015). 
 
 
Stress Granules  
 
Stress granules are cytoplasmic granules composed of mRNA and proteins that 
form in response to stalled translation during cell stress (Anderson et .al., 2015; Molliex 
et. al., 2015; Buchan and Parker, 2009). Once stress signals are removed and translation 
has been re-initiated, stress granules dissolve (Mitrea and Kriwacki, 2015). In recent 
years, stress granules have been linked to various degenerative diseases such as 
amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy (Li, 
et. al., 2013; Ramaswami, et. al., 2013). For instance, disease mutations found within low 
complexity domains (i.e., disordered regions comprised of only a few amino acids) of 
heterogeneous nuclear ribonucleoproteins A2B1 and A1 (hnRNPA2B1 and hnRNPA1, 
respectively) have been shown to promote their incorporation into stress granules and 
formation of fibrillar structures within cytoplasmic inclusions (Kim, et. al., 2013). 
Furthermore, it is believed that fibril formation is promoted over time, with extensive 
stress granule formation and dissolution, and that fibril formation is enhanced with the 
disease causing mutants (Molliex, et. al., 2015). Another stress granule protein harboring 
low complexity domains shown to be implicated in disease is the fused in sarcoma (FUS) 
RNA-binding protein (Burke, et. al., 2015; Sharma, et. al., 2015). Like hnRNPA2B1 and 
hnRNPA1, it is believed that low complexity regions of FUS (i.e., [G/S]Y[G/S] repeats) 
undergo fibril formation over time and contribute to the disease state of stress granules 
(Han, et. al., 2012; Kato, et. al., 2012). 
 
 
Liquid-Liquid Phase Separation 
 
As previously stated, unlike their lipid-bound cousins, membrane-less organelles 
do not have a physical barrier to separate their components from the surrounding nucleo- 
or cytoplasm, which raises the questions as to how these organelles exist and why their 
components do not simply mix with the surrounding environment. Recently, it has been 
suggested that membrane-less organelles are able to form through concentration- 
dependent LLPS and therefore behave as liquids (Brangwynne, et. al., 2009; Han, et. al., 
2012; Hyman, et. al., 2014; Molliex, et. al., 2015; Weber and Brangwynne, 2015). To be 
a liquid, components must be able to quickly and readily rearrange and exchange with 
components in the surrounding environment (Hyman, et. al., 2014). Components that 
make up the liquid-like membrane-less organelle interact with one another in a soluble 
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one-phase state, but as the degrees of interactions are increased (e.g., through increases in 
protein concentration), a point is reached where it is more entropically favorable for the 
components to demix with the surrounding liquid environment to form a two-phase 
separated state (Figure 1-1), much like oil and water (Hyman, et. al., 2014).  
 
Many proteins found within membrane-less organelles are disordered or contain 
disordered regions, which allows for increased protein flexibility and mobility and allows 
for rapid exchange into and out of the organelle, thus enabling dynamic, liquid-like 
behavior (Nott, et. al., 2015; Guo and Shorter, 2015; Elbaum-Garfinkle, et. al., 2015; 
Molliex, et. al., 2015; Amen and Kaganovich, 2015; Feric, et. al., 2016; Hyman, et. al., 
2014; Burke, et. al., 2015). In addition to the presence of low complexity regions, 
multivalent interactions between complementary binding motifs have been shown to 
promote LLPS. Recently, Rosen, et al., described one molecular mechanism for the 
formation of liquid-like droplets as being driven by weak, multivalent protein-protein 
interactions. Specifically, they found that engineered proteins with multiple SH3 domains 
phase separate to form liquid-like droplets when mixed with binding partners containing 
multiple proline-rich motifs (Li, et. al., 2012; Banjade and Rosen, 2014; Su, et. al., 2016). 
The weak, multivalent interactions were strong enough to form molecular assemblies, but 
weak enough to maintain the dynamics required for droplet fluidity. Moreover, when 
valency was increased, the phase separation concentration threshold decreased. In 
addition to component concentration, pH, salt concentration, temperature, and osmolarity 
have also been shown to mediate LLPS (Berry, et. al., 2015; Elbaum-Garfinkle, et. al., 
2015; Nott, et. al., 2015; Molliex, et. al., 2015; Zhang, et. al., 2015). 
 
 
The Nucleolus and Ribosome Biogenesis 
 
Shortly after the introduction of microscopy, roughly in the mid-1800’s, biologists 
observed small, dense bodies in the center of nuclei, which Valentin in 1836 termed the 
‘nucleolus’ (Pederson, 2010). Nucleoli are eukaryotic nuclear membrane-less organelles 
that are the site for ribosome biogenesis and a sensor of cellular stress (Tafforeau, et. al., 
2013). Nucleoli assemble around actively transcribing ribosomal RNA (rRNA) genes 
(rDNA), termed nucleolar organizing regions (NORs), and are formed through dynamic, 
but specific, interactions between rRNA, rDNA, and numerous proteins. NORs are found 
on the short arms of the five acrocentric chromosomes resulting in roughly 600 rDNA 
repeats per diploid cell and potentially 10 nucleoli per cell (Boisvert, et. al., 2007). 
Nucleolar formation and disassembly is regulated by the cell cycle in that assembly 
begins at the beginning of G1 when rDNA transcription is initiated producing fully 
assembled nucleoli during S phase; nucleoli begin to disassemble at the beginning of 
prophase as rDNA transcription machinery becomes phosphorylated leading to 
termination of transcription and diffusion of proteins out of the outer granular component 
(GC) region of the nucleolus (Boisvert, et. al., 2007; Hernandez-Verdun, 2011). 
 
Transcription of rDNA occurs at the boundary between the fibrillar center (FC) 
and the dense fibrillar component (DFC) (Boisvert, et. al., 2007). Successive rRNA 
splicing and modification occurs in the DFC. Further maturation of pre-rRNA and  
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Figure 1-1. Concentration Dependent Phase Diagram 
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assembly of pre-ribosomal subunits occurs in the GC (Boisvert, et. al., 2007). The final 
assembly steps occur in the nucleoplasm and cytoplasm, leading to the formation of 
complete 80S ribosomes. Disrupting ribosome biogenesis and nucleolar stability (e.g., 
mutations in ribosomal proteins or rRNA processing machinery) has been linked to 
human diseases including various ribosomopathies, Werner syndrome, Rothmund-
Thomson syndrome, and various cancers (Boisvert, et. al., 2007; Montanaro et. al., 2008). 
For example, mutations within the gene encoding the small subunit ribosomal protein, 
rpS19, have been shown to disrupt 18S rRNA maturation and thus pre-40S subunit 
production; such alterations in ribosome biogenesis ultimately lead to drastic reduction in 
erythroid precursor cells, a disease more formally known as Diamond-Blackfan anemia 
(Boisvert, et. al., 2007). Disrupting nucleolar integrity, either by overexpression or down-
regulation of nucleolar proteins has also been shown to be involved in the genesis of 
various cancers (Frye, et. al., 2010; Montanaro, et. al., 2008; Romanova, et. al., 2006). In 
fact, enlarged nucleoli, most likely due to increased ribosome production, is a hallmark of 
highly proliferative cells and is commonly used as a phenotypic marker for cancerous 
cells (Derenzini, et. al., 2009; Montanaro, et. al., 2008). Although the individual 
processing and maturation steps that are required for ribosome production as well as 
stress response pathways are known, the molecular basis for nucleolar organization and 
how this influences the molecular processes within the nucleolus are poorly understood. 
 
Recently, Brangwynne, et al. (2011), demonstrated that nucleoli from Xenopus 
oocytes exhibit “liquid droplet-like” behavior, including the ability to fuse in vitro. 
Fibrillar centers were shown to be round but rarely exhibited fusion with other FCs; 
however, the GC, comprised of rRNA and proteins, underwent fusion and displayed other 
fluid-like characteristics. Furthermore, it is believed that differences in surface tension 
between these compartments prevents mixing and thus is responsible for tripartite 
nucleolar organization (Feric, et. al., 2016). We hypothesize that the liquid-like nature of 
nucleoli arises from a vast network of multivalent protein-protein and protein-rRNA 
interactions within the GC. Further, based upon our published and unpublished data, we 
hypothesize that the nucleolar protein, Nucleophosmin 1 (NPM1), is a central component 
of this network and is thus critical for the organization of the GC. 
 
 
Nucleophosmin 1 
 
 Nucleophosmin 1 (NPM1, also referred to as B23, NO3, and numatrin) is a 
multifunctional protein playing roles in ribosome biogenesis, centrosome duplication, 
tumor suppression, and as a molecular chaperone and is highly expressed in the nucleolar 
GC (Grisendi, et. al., 2006; Grisendi, et. al., 2005). NPM1 overexpression is observed in 
multiple cancers (e.g., gastric, colon, ovarian, and prostate carcinomas) and mutations 
within the C-terminal nucleic acid binding domain that cause cytoplasmic localization of 
NPM1 are observed in over 50% of adult acute myeloid leukemia (AML) cases (El Hajj, 
et. al., 2015; Falini, et. al., 2007; Grisendi, et. al., 2006). Moreover, NPM1 knockout in 
mice is embryonic lethal, and derived embryonic fibroblasts are viable only when p53 is 
concomitantly deleted (Grisendi, et. al., 2005). NPM1 exhibits several domains that 
enable interactions with diverse protein and RNA partners. Specifically, NPM1 contains 
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an N-terminal oligomerization domain (termed OD, residues 1-120), a central disordered 
region, and a C-terminal nucleic acid binding domain (termed CTD, Figure 1-2) (Mitrea, 
et. al, 2014). An NPM1 monomer exhibits three acidic tracts (A1-A3; A1, residues 34-39; 
A2, residues 120-132; A3, residues 161-188), which create multivalent acidic patches for 
binding to other proteins; this multivalency is amplified due to NPM1 pentamerization 
(Figure 1-3). Recently, using a truncated construct, termed N130 (OD + A2; residues 1-
130), A1 and A2 were shown to interact with peptides derived from proteins containing 
disordered regions with multiple arginine-rich motifs (R-motifs); furthermore, binding of 
an arginine-rich peptide to N130 promoted pentamer formation even with a monomeric 
phospho-mimetic form of N130, N130S88E (Mitrea, et. al., 2014). In addition, the CTD 
has been shown to bind to various nucleic acid species including rRNA (Wang, et. al., 
1994).  
 
Based upon these observations, we propose that multivalent interactions between 
NPM1’s acidic tracts and R-motifs within its nucleolar binding partners contribute to the 
GC’s liquid-like behavior. We further propose that this dynamic behavior can be 
modulated by changing ionic strength and through incorporation of rRNA into the phase 
separated network. We first analyzed a list of NPM1 binding partners to identify 
sequences that we hypothesized would be sufficient for LLPS. Using a minimalistic 
approach, I next tested if NPM1 could phase separate with R-rich linear motifs using 
microscopic techniques and, by ITC, found that LLPS was promoted by a network of 
weak, electrostatic interactions. I then transitioned to using longer protein constructs in 
order to measure changes in protein dynamics within the droplets in response to the 
addition of rRNA and changes to valency. Through these experiments, we were able to 
gain insight into the relationships between molecular features of droplet components and 
bulk droplet properties (i.e., protein dynamics within droplets). Altogether, through these 
experiments, we were able to gain an understanding of the types of interactions that are 
required for in vitro droplet formation by NPM1 with its nucleolar protein and rRNA 
partners. 
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Figure 1-2. Structural Features of Monomeric Nucleophosmin 1 
 
 
 
 
 
 
Figure 1-3. Pentameric Structure of Nucleophosmin 1 
NPM1 forms a pentamer through its N-terminal oligomerization domain (OD, green; 
PDB ID 4N8M) and contains a disordered central region (grey), and a folded C-terminal 
nucleic acid binding domain (CTD, blue; PDB ID 2VXD). NPM1 also harbors three 
acidic tracts per monomer (A1-A3, red). 
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CHAPTER 2.    MATERIALS AND METHODS 
 
 
Bioinformatics 
 
  A list of 132 NPM1-binding proteins obtained from BioGRID (Huttlin, et. al., 
2015) was analyzed using the DAVID Bioinformatics Resources 
(http://david.abcc.ncifcrf.gov) (Huang da, et. al., 2009) to identify those with known 
involvement in nucleolar structure and/or function. GO terms were available for 125 of 
the 132 NPM1-binding proteins (Mitrea, et. al., 2016).  Minimal R-motifs were defined 
as follows: a minimal, single R-motif as the sequence pattern, RXn1R, where n1 ≤ 2, R is 
arginine and X is any amino acid; a minimal, multivalent R-motif as the sequence pattern, 
Rn1Xn2Rn1Xn3Rn1Xn2Rn1; where n1 > 1, 0 ≤ n2 ≤ 2, 3 ≤ n3 ≤ 20). A Python algorithm was 
developed to identify proteins exhibiting multivalent R-motifs and was applied to the list 
of NPM1-binding proteins as well as a list of 20,193 non-redundant human proteins 
obtained from the UniProtKB/Swiss-Prot database (http://www.uniprot.org/uniprot/) 
(UniProt, 2014).  
 
 
Cloning, Protein Expression, and Purification 
 
  The N130 construct (Appendix A (Figures A-1 to A-4; Table A-1)), cloned into 
the pET28a vector, was expressed and purified as described previously (Mitrea, et. al., 
2014). N294 construct (Table A-1) genes were cloned as previously described (Mitrea, 
et. al., 2016), however the original PreScission protease cleavage site following the 6xHis 
tag was replaced with a TEV protease cleavage site. R-protein constructs (Table A-1), 
derived from their respective human genes, were cloned between NdeI and SalI 
restriction sites and subcloned into the pET28a vector (Novagen) with a TEV cleavage 
site following the 6xHis affinity tag. Both N294 and R-proteins, excluding SURF6, were 
expressed in E. coli strain BL21(DE3) in Luria Broth. The SURF6 protein was expressed 
in E. coli strain Rosetta(DE3) in Luria Broth. The N294 protein expression was induced 
with 100 mg/L isopropyl β-D-1-thiogalactopyranoside (IPTG) (Goldbio) at OD600 ~0.6, 
and cultures were incubated overnight at 18 oC. Expression of the GNL2 and RPL23a 
proteins was induced with 100 mg/L IPTG at OD600 ~0.8, and cultures were incubated for 
3-4 hours at 30 oC. Expression of the SURF6 protein was induced with 100 mg/L IPTG at 
OD600 ~0.7, and cultures were incubated overnight at 18 
oC. Bacterial cells were 
harvested by centrifugation and the proteins were purified as follows.  
 
N294 cells were lysed by sonication in 10 mM Tris, 300 mM NaCl, 10 mM β-
mercapto-ethanol (BME), pH 7.5 supplemented with protease inhibitors (SigmaFAST, 
Sigma-Aldrich). The soluble fraction of protein was collected by centrifugation and 
purified by Ni-NTA affinity chromatography. The N294 protein was eluted using 0.5 M 
imidazole in the buffer and dialyzed overnight against 10 mM Tris, 150 mM NaCl, 2 mM 
dithiothreitol (DTT), pH 7.5 in the presence of TEV protease to cleave the 6xHis-tag. 
N294 was further purified by HPLC. The lyophilized protein was resuspended in 6 M 
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guanidine hydrochloride and refolded by dialyzing against 10 mM Tris, 150 mM NaCl, 2 
mM DTT, pH 7.5. Proper protein folding was verified by circular dichroism (CD).  
 
E. coli cells expressing the RPL23a (Figure A-1) protein were lysed by 
sonication in cold 50 mM sodium phosphate buffer (NaP), 300 mM NaCl, 2% glycerol, 
pH 8.0 supplemented with protease inhibitors and benzonase endonuclease. The soluble 
fraction of protein was collected by centrifugation and purified by Ni-NTA affinity 
chromatography using 0.5 M NaCl in buffers. RPL23a was eluted using buffer with 0.3 
M imidazole and dialyzed overnight against 10 mM Tris, 300 mM NaCl, 2 mM DTT, 2 
mM EDTA, pH 8.0 in the presence of TEV protease to cleave the 6xHis-tag RPL23a was 
further purified by HPLC. The lyophilized protein was resuspended in 6 M guanidine 
hydrochloride and refolded by dialyzing against 10 mM Tris, 150 mM NaCl, 2 mM DTT, 
pH 7.5. Proper protein folding was verified by CD (Appendix B (Figures B-1 to B-2; 
Table B-1)). Because the nucleolin, GNL2, and SURF6 proteins expressed are 
disordered, these proteins had to be purified under denaturing conditions.  
 
E. coli cells expressing the Nucleolin (Figure A-2) and GNL2 (Figure A-3) 
proteins, separately, were lysed by sonication in 100 mM NaP, 10 mM Tris, 6 M 
guanidine HCl, pH 8.0. The soluble protein was collected by centrifugation and purified 
by Ni-NTA affinity chromatography using 25 mM Tris, 500 mM NaCl, 20 mM 
imidazole, 3 M urea, pH 8.0. The protein was eluted with 0.3 M imidazole in the buffer. 
The eluted protein was dialyzed overnight against 10 mM Tris, 200 mM NaCl, 2 mM 
DTT, 1 mM EDTA, pH 8.0 in the presence of TEV protease to cleave the 6xHis tag. The 
cleaved protein was subsequently purified by HPLC, and the lyophilized protein was 
resuspened in 6 M guanidine HCl and dialyzed against 10 mM Tris, 500 mM NaCl, 2 
mM DTT, pH 7.5. Protein disorder was verified by CD (Figure B-2). 
 
E. coli cells expressing the SURF6 (Figure A-4) protein were resuspended in 25 
mM NaP, 0.1% Triton X-100, pelleted by centrifugation, and lysed by sonication in 25 
mM NaP, 300 mM NaCl, 6 M guanidine HCl, 5 mM BME, pH 7.0. Soluble protein was 
collected by centrifugation and purified by Ni-NTA affinity chromatography using 0.5 M 
NaCl in buffers. Protein was eluted with 0.5 M imidazole containing buffers and dialyzed 
overnight against 10 mM NaP, 150 mM NaCl, 2 mM DTT, pH 7.0 in the presence of 
TEV protease to cleave the 6xHis tag. Likewise, SURF6 was further purified by HPLC 
and the lyophilized protein was resuspened in 6 M guanidine HCl and dialyzed against 10 
mM Tris, 500 mM NaCl, 2 mM DTT, pH 7.5. Protein disorder was verified by CD 
(Figure B-2). 
 
The N130 construct was chemically labeled with Alexa Fluor488 C5 maleimide 
(Life Technologies) as previously described (Mitrea, et. al., 2016). Similarly, N294 was 
labeled with Alexa Fluor488 C5 maleimide (Life Technologies) following the 
manufacturer’s protocol. To ensure selective labeling at the solvent exposed Cys104, 
Cys21 and Cys275 were mutated to a threonine. Labeling was carried out in 10 mM Tris, 
150 mM NaCl, pH 7.5. Excess dye was removed by dialysis. The N-termini of GNL2 and 
SURF6 were chemically labeled with Alexa Fluor555 NHS-ester (Life Technologies) 
according to the manufacturer’s protocol. Prior to labeling, the proteins were dialyzed 
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against 20 mM NaP, 500 mM NaCl, 2 mM DTT, pH 7.0. Labeling was carried out in the 
same buffer. Excess dye was removed by dialysis.  
 
 
Peptide Synthesis 
 
 Peptides used for ITC and LLPS screening assays were synthesized by the 
Macromolecular Synthesis resource within St. Jude Children’s Research Hospital’s 
Hartwell Center for Bioinformatics and Biotechnology. 
 
 
Determination of Protein, Peptide, and RNA Concentrations 
 
 Protein concentrations were calculated in denaturing conditions using a 1 mm 
cuvette to measure their absorbance at 280 nm and their respective extinction coefficient 
(Table B-1). Lyophilized peptides were dissolved in 10 mM Tris, 150 mM NaCl, pH 7.5 
and concentrations were calculated using the same method as proteins. RNA 
concentrations were calculated using the nucleic acid setting on a NanoDrop 2000c UV-
Vis Spectrophotometer (Thermo Scientific). 
 
 
Isothermal Titration Calorimetry 
 
 Titrations were performed using an Auto-iTC200 instrument (formerly GE 
Healthcare, now Malvern), at 25 °C, with N130 or N122 in the cell. Lyophilized peptides 
were dissolved in 10 mM NaP, 150 mM NaCl, 2 mM DTT, pH 7.0 and dialyzed 
overnight against the fresh NaP buffer to eliminate residual TFA. Protein and peptide 
concentrations were selected to be below the phase separation threshold to prevent LLPS 
during the experiments. Data was analyzed using Origin Software to obtain 
stoichiometries (n), enthalpies of binding (?H) and dissociation constants (Kd).      
 
 
Turbidity Measurements 
 
 Proteins and peptides or peptides and wheat germ rRNA (bioPLUS) were mixed 
to a final volume of 10 μl. Samples were incubated for 5 minutes at room temperature 
prior to analysis. Absorbance at 340 nm for 3 μL samples was measured on a NanoDrop 
2000c UV-Vis Spectrophotometer (Thermo Scientific). Measurements were performed in 
triplicate.   
 
 
Slide Coating for Microscopy 
 
 CultureWell 16-well chambered cover glass slides (Grace BioLabs) were washed 
with detergent and ethanol and dried prior to being treated with PlusOne Repel-Silane ES 
(GE Healthcare). Slides were subsequently washed with ethanol and water, dried, and 
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coated with 1% PF-127 (Sigma). Slides were covered and left overnight at room 
temperature. PF-127 solution was removed and slides were dried immediately prior to 
use. 
 
 
Fluorescence Microscopy 
 
 Initially, wide field microscopy DIC and 488 nm fluorescent images were 
collected to screen for droplet formation and map phase diagrams with N130 and 
peptides on a Nikon C1Si microscope with a 60x magnification oil objective (Nikon 
Instruments). 10 μl samples, spiked with 1 μM Alexa Fluor488-N130, were incubated at 
room temperature for 5 minutes prior to analysis. Droplets were defined as having an area 
greater than 9 squared pixels (0.2 μm/pixel) and circularity of 0.5-1, which were 
measured using ImageJ. Particles smaller than 9 squared pixels were visible by 
fluorescence but not DIC at low protein and peptide concentrations; however, these 
objects were below the threshold to confidently measure circularity. Therefore droplet 
formation was not recorded until particles could be observed by DIC. DIC and 488 nm 
fluorescent images of droplets using different peptide linker lengths were acquired by 
confocal microscopy on the same instrument and with the same objective. For droplets 
with longer constructs, 75 μL samples, spiked with 1 μM Alexa Fluor488-N294 and 2 
μM Alexa Fluor555-Surf6 or 5 μM Alexa Fluor555-GNL2, were incubated at room 
temperature in chamber well slides for 30 min to allow droplets to form and fuse with one 
another prior to analysis. 488 nm and 561 nm fluorescent images were acquired on a 
Zeiss Axio Observer microscope (Carl Zeiss Microscopy) equipped with CSU-X 
spinning disk confocal heads (Yokagawa) using a 100x magnification objective with oil. 
Images were analyzed using SlideBook software.  
 
 
Fluorescence Recovery after Photobleaching 
 
Fluorescence recovery after photobleaching (FRAP) experiments were performed 
on the same equipment as described above for SURF6, GNL2, RPL23a, and Nucleolin. A 
circular area of ~ 1 μm in diameter at the center of droplets was photobleached using a 
488 nm laser for Alexa488-labeled N294 at 100% power and recovery was monitored, for 
3 minutes or until recovery plateaued, at 0 ms intervals between points. Similarly, in 
separate droplets, ~1 μm in diameter areas were photobleached with a 561 nm laser for 
Alexa561-labeled SURF6 or GNL2. FRAP data was normalized to the background 
fluorescence (Equation 1-1) where FROI is the fluorescence intensity inside the bleached 
region at times t after photobleaching, and F0 is the ROI fluorescence intensity before 
photobleaching. Fbackground is the fluorescence intensity at times t of an area outside of a 
droplet.  
 
                                                        F?t??= FROI-Fbackground
F0-Fbackground
  (Eq. 1-1) 
                                                                        
N294/GNL2 recovery curves were best fit to a nonlinear regression curve 
(Equation 1-2) where F0 and F∞ are the fluorescent intensities of the bleached region 
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immediately following photobleaching and at full recovery, respectively, and t1/2 is the 
half-time of recovery.  
 
                                                          F?t??= 
F?? ?F∞
?
????
?? ? ?????
  (Eq. 1-2) 
 
N294/SURF6 curves were best fit to a single exponential (Equation 1-3), where 
A is the maximum fluorescence recovery and directly correlates to the mobile fraction of 
protein and τ is the recovery timescale.  
 
                                                          F?t??= A(1-e-t*τ?  (Eq. 1-3) 
 
 The rate of diffusion can then be estimated using the half-time of recovery, t1/2, or 
the recovery timescale, τ, and the bleached radius, w (Equation 1-4 and Equation 1-5) 
(Elbaum-Garfinkle, et. al., 2015; Kang et. al., 2012). 
 
                                                                D  = w
2
?
  (Eq. 1-4) 
 
 
                                                               D  = w
2
4t1/2
  (Eq. 1-5) 
  
Normalized FRAP curve fitting and diffusion plots were generated using KaleidaGraph 
software. P values were calculated using the GraphPad t test calculator freely available 
online (http://www.graphpad.com/quickcalcs/). 
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CHAPTER 3.    RESULTS 
 
 
Characterizing Features of NPM1 Binding Partners 
 
We first sought to determine if R-motifs were a common feature of NPM1 
binding partners. To gain insight into the molecular basis for interactions with NPM1, we 
determined the occurrence of multivalent R-motifs within the sequences of the 132 
NPM1-binding proteins, identified in HEK293T cells by affinity mass spectrometry 
(Huttlin, et. al., 2015). We found that over 73% of these proteins exhibited at least one 
multivalent R-motif; in contrast, only 44% of all human proteins exhibited a multivalent 
R-motif (Mitrea, et. al., 2016). These data show that NPM1 binding partners are enriched 
in multivalent R motifs, when compared to the human proteome (p < 0.0001). 
Furthermore, analysis of Gene Ontology terms indicated that over 50% of the NPM1 
binding partners were nucleolar proteins (Mitrea, et. al., 2016). Using the protein disorder 
predictor, IUPred, we found that most of the proteins are predicted to be completely 
disordered or contain disordered regions which harbor most, if not all, of the multivalent 
R-motifs (Supplemental Data for Chapter 3). 
 
Next, we analyzed a library of R-motif containing peptides (R-peptides), derived 
from nucleolar proteins identified above (Table 3-1), to confirm binding to NPM1 and to 
measure binding affinities. As we wanted to maintain a minimalistic system, we used an 
NPM1 construct capable of forming a pentamer which contained acidic tracts A1 and A2 
(termed N130) and a construct with only A1 (termed N122). The synthetic R-peptides 
were made to only include the multivalent R-motif. An additional RPL521-37 peptide was 
constructed, termed RPL5-RA, in which the second R-motif (RKR) was changed to AKA 
in order to test the importance of multivalency on binding stoichiometry and affinity. We 
then used isothermal titration calorimetry (ITC) to confirm binding, measure equilibrium 
dissociation constants, and calculate binding stoichiometry. We observed differences in 
binding affinity and capacity for each of the peptides binding to N122 and N130 (Figure 
3-1 and Table 3-2).  RPL23a47-68 has three possible R-motifs that could potentially 
interact with NPM1, with different affinities; the ITC curve produced from RPL23a and 
N130 exhibited multimodal binding and therefore could not be fit using the standard 
binding models available in the manufacturer’s Origin software. Multiple binding events 
were also observed with GNL2682-709 and N130. With N122, RPL5-RA bound at roughly 
1:1 stoichiometry, whereas the other peptides exhibited N values below one, indicative of 
either peptide aggregation or multiple N122 monomers per peptide. The presence of two 
R-motifs increased binding affinity as the RPL5-RA bound to N122 and N130 at much 
lower affinities than the other peptides, 61.4 μM (RPL5-RA) versus 10-20 μM (other 
peptides) for N122 and 89 μM (RPL5-RA) versus roughly 20 μM (other peptides) for 
N130. Furthermore, binding capacity was increased from N=1 to N=2 for peptides 
containing more than one R-motif when an additional acidic tract was present (i.e., with 
N130). 
 
We were able to show that R-rich motifs are common sequence features of NPM1 
binding partners and that peptides containing these motifs were able to bind to the N-  
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Table 3-1. Synthetic Peptides of NPM1 Binding Partners 
 
Peptide Sequence 
RPL23a47-68 RRPKTLRLRRQPKYRKSAPRR 
GNL2682-709 RRRAVRQQRPKKVGVRYYEHNVKNRNR 
SURF6299-326 RRAQRQRRWEKRTAGVVEKMQQRQDRRR 
RPL521-37 RRRREGKTDYYARKRLV 
RPL5-RA RRRREGKTDYYAAKALV 
RPL5-20L RRRRGSGSGSGSGYYSGSGSGSGSRKRLV 
RPL5-16L RRRRGSGSGSGYYSGSGSGSRKRLV 
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Figure 3-1. ITC Curves for NPM1 with R-Peptides 
Respective ITC curves for R-peptide titrations into N122 (top) and N130 (bottom). 
Concentrations were kept below the phase separation threshold. The curves represent one 
of the three titrations for each peptide.  
 
Reprinted with permission from: Mitrea, D. M., Cika, J. C., Guy, C. S., Ban, D., 
Banerjee, P. R., Stanley, C. B., Nourse, A., Deniz, A. A., Kriwacki, R. W. (2016). 
Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins 
displaying R-rich linear motifs and rRNA. eLife, 5. 
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Table 3-2. ITC Data for NPM1 with R-Peptides 
 
  N122  N130 
Peptide  N (sites) KD (μM)
  N (sites) KD (μM)
 
RPL23a47-68  n.d.# n.d.#  n.d.* n.d.* 
GNL2682-709  0.66 ± 0.04 10.2 ± 1.3  n.d.* n.d.* 
SURF6299-326  0.55 ± 0.06 9.2 ± 0.5  1.4 ± 0.02 19.0 ± 0.8 
RPL521-37  0.63 ± 0.09 19.0 ± 2.7  2.2 ± 0.19 20.5 ± 5.0 
RPL5-RA  1.18 ± 0.06 61.4 ± 0.5  1.2 ± 0.07 88.9 ± 0.3 
 
*Not determined due to multiple, unresolved binding events. #Heat change was too weak 
for accurate data analysis. Data was averaged from a minimum of three independent 
experiments ± SD. 
 
Reprinted with permission from: Mitrea, D. M., Cika, J. C., Guy, C. S., Ban, D., 
Banerjee, P. R., Stanley, C. B., Nourse, A., Deniz, A. A., Kriwacki, R. W. (2016). 
Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins 
displaying R-rich linear motifs and rRNA. eLife, 5. 
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terminal oligomerization domain and a portion of the central disordered region, 
presumably via A1 and A2 (Mitrea et. al., 2014), with μM Kd values. Next we wanted to 
test whether these multivalent R-motifs were sufficient for phase separation into liquid-
like droplets with NPM1. 
 
 
Survey for Droplet Formation with NPM1 and Peptides 
 
Based on published work on membrane-less organelles and phase separation 
(Brangwynne et. al., 2011; Li et. al., 2012), we hypothesized that multivalent interactions 
between NPM1 and the identified R-motif-containing nucleolar proteins and rRNA 
contribute to the liquid-like nucleolar environment and would promote droplet formation 
in vitro. We started with a minimalistic system analyzing only multivalent R-motif 
peptides and N130 as was done with ITC experiments discussed above. Using a 
fluorescently labeled N130 construct (A488-N130) we analyzed for droplet formation by 
microscopy at various concentrations in order to map a phase diagram for each peptide. 
In support of our hypothesis, each of the peptides underwent LLPS with N130 (Figure  
3-2). Next we tested how the length of the linker between R-motifs within a multivalent 
R-motif peptide alters droplets morphology. For this, we used a synthetic RPL5 peptide 
with the residues between the R-motifs altered to include varying lengths of glycine-
serine (GS) repeats (RPL5-20L with a 20 residue-long linker and RPL5-16L with a 16 
residue-long linker; Table 3-1). N130 and the peptides were mixed under conditions 
associated with LLPS by the wild type RPL5 peptide (1:3 N130:RPL5 peptide molar 
ratio, 200 μM N130). As was observed with the wild type RPL5 peptide, these divalent 
peptides phase separated with N130 to form liquid-like droplets; furthermore, larger 
droplets were observed as the linker length was increased (Figure 3-3). To confirm that 
divalency of R-motifs was required for LLPS, we tested whether the monovalent RPL5 
peptide, RPL5-RA (Table 3-1) underwent phase separation with N130; as expected, 
LLPS was not observed (Mitrea, et. al., 2016).  Finally, we addressed the requirement for 
multivalency of acidic tracts within N130 for LLPS with bivalent R-motif peptides by 
performing experiments with N122, which lacks the A2 acidic tracts.  N122 was mixed 
with RPL5 and RPL5-R2A peptides and turbidity was measured to monitor phase 
separation. N122 did not undergo LLPS with any of the peptides, showing that bivalency 
of acidic tracts within a N130 subunit is required for phase separation (Mitrea et. al., 
2016). These data have shown that R-motifs bind to NPM1 acidic tracts, A1 and A2, via 
weak, electrostatic interactions, and that phase separation requires a highly multivalent 
system.  
 
As rRNA is a major nucleolar component, we next tested if the R-peptides could 
also undergo LLPS with wheat germ rRNA. Using various concentrations of rRNA and 
R-peptides, we measured turbidity of the solution as an indication of phase separation. 
Indeed, each of the peptides underwent phase separation with rRNA; however, when 
these solutions were analyzed by differential interference contrast (DIC) microscopy, we 
observed small puncta (~ 1 μm in diameter) rather than droplets (Figure 3-4). 
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Figure 3-2. N130 Phase Separates with a Variety of R-Motifs Containing Peptides 
Phase diagrams for each of the multivalent R-motif peptides analyzed. Peptides were 
titrated into N130 (spiked with 1 μM Alexa Fluor488) and imaged by wide field 
microscopy. Images, DIC (top) and Alexa Fluor488 N130 emission (bottom) shown are 
at 50 μM N130 and the lowest peptide concentration where droplet formation was 
observed. Scale bar: 5 μm 
 
Reprinted with permission from: Mitrea, D. M., Cika, J. C., Guy, C. S., Ban, D., 
Banerjee, P. R., Stanley, C. B., Nourse, A., Deniz, A. A., Kriwacki, R. W. (2016). 
Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins 
displaying R-rich linear motifs and rRNA. eLife, 5. 
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Figure 3-3. Linker Length Dictates N130 Droplet Size 
Confocal images, DIC (bottom) and Alexa Fluor488 N130 emission (top) shown are at 
200 μM N130 (including 2 μM Alexa Fluor488 N130) and 600 μM peptide. Droplets 
were imaged 1 hour after mixing. Scale bar: 10 μm. 
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Figure 3-4. Phase Separation of R-Peptides with rRNA by Turbidity 
Absorbance measured at 340 nm 5 minutes after mixing. A. Titrations of wheat germ 
rRNA into each 50 μM peptide. B. Titrations of each peptide into 50 μg/mL wheat germ 
rRNA. C. DIC images of 25 μM R-peptide into 50 μg/mL rRNA. Scale bar: 10 μm. 
 
Reprinted with permission from: Mitrea, D. M., Cika, J. C., Guy, C. S., Ban, D., 
Banerjee, P. R., Stanley, C. B., Nourse, A., Deniz, A. A., Kriwacki, R. W. (2016). 
Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins 
displaying R-rich linear motifs and rRNA. eLife, 5. 
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Survey for Droplet Formation with Longer Constructs and rRNA 
 
We next extended our studies to address the role of R-motifs within full-length 
proteins, or long protein segments, in interactions with full-length NPM1, as well as its 
interactions of rRNA (Figure 3-5a). We prepared constructs for proteins from which 
three of our R-peptides (SURF61-182, GNL2630-731, and RPL23a1-156) were derived and for 
an additional nucleolar protein, Nucleolin610-709. Each of these constructs are predicted to 
be disordered or contain disordered regions containing the multivalent R-motifs (Figure 
3-5a). Due to problems purifying the full-length SURF6 (360 residues) protein, we used a 
construct with the first 182 residues which contains six R-motifs. Full-length RPL23a 
was able to be purified and was used in the following experiments. As GNL2 and 
Nucleolin are much larger proteins (over 700 residues) we made constructs 
corresponding to their C-terminal disordered regions which contained the multivalent R-
motifs that were predicted to interact with NPM1 and promote phase separation. In 
addition to studying these longer R-protein constructs, we also began studying full-length 
NPM1 (N294), which contains an additional acidic tract (A3) and the C-terminal nucleic 
acid binding domain (CTD), rather than N130.  
 
The various R-proteins were mixed with NPM1 and confocal microscopy was 
used to monitor phase separation into liquid-like droplets. For these experiments, a small 
amount of fluorescently-labeled mutant NPM1 (Cys 21 and Cys 275 mutated to Thr) was 
mixed with an excess of wild-type NPM1. As we observed with R-motif containing 
peptides, each of the R-proteins were able to phase separate with N294, however not all 
R-proteins formed liquid-like droplets. Specifically, SURF6/N294 and RPL23a /N294 
formed droplets which fused, GNL2/N294 formed non-fusing droplets, and 
nucleolin/NPM1 did not form droplets, but rather phase separated into a solid-like state 
(Figure 3-5b). Using the same microscopic approach, we next tested if NPM1 could 
phase separate with the same wheat germ rRNA as used with the peptides, as NPM1 
harbors the CTD that binds nucleic acids. Indeed, NPM1 and rRNA phase separated to 
form liquid-like droplets (Figure 3-6a); furthermore, nucleolin, which did not form 
liquid-like droplets with N294, became incorporated into N294/rRNA droplets (Figure  
3-6b). To test if NPM1 is required for R-proteins to undergo LLPS with rRNA, we used 
our longest R-protein construct with the most R-motifs, SURF6 and, using confocal 
microscopy, monitored droplet formation with 100 μg/mL rRNA. Unlike the R-peptides, 
SURF6 formed liquid-like droplets with only rRNA; imaging the droplets 18 hours later, 
we observed that these droplets remain smaller overtime than N294/SURF6 and 
N294/SURF6/rRNA droplets (Figure 3-6c). Furthermore, droplets formed in the absence 
of rRNA appeared larger than those formed with rRNA. 
 
 
Measuring Protein Dynamics within NPM1 and Arginine-Rich Nucleolar Protein 
Droplets  
 
After establishing that NPM1 phase separated with a variety of nucleolar binding 
partners, R-proteins and rRNA, we next sought to determine how modulating the 
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Figure 3-5. N294 Phase Separates with a Variety of R-Proteins 
A. Schematics of the studied R-proteins with R-motifs highlighted in blue. PONDR 
disorder prediction plots correspond to the truncated protein. R-motifs are highlighted in 
blue. B. 10 μM N294 with 20 μM R-proteins, spiked with 1 μM A488-N294. Scale bar: 
10 μm 
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Figure 3-6. rRNA Promotes LLPS with NPM1 and R-Proteins 
A. 10 μM N294, spiked with 1 μM A488-N294, with 50 μg/mL rRNA B. 10 μM N294, 
spiked with 1 μM A488-N294, with 10 μM A555-Nucleolin, and 50 μg/mL rRNA. C. 
Confocal images collected 30 minutes after mixing and after overnight incubation at 
room temperature of 20 μM SURF6 (spiked with 2 μM Alexa Fluor555 SURF6) with 
100 μg/mL wheat germ rRNA (left), 20 μM N294 (middle), and the tertiary mixture 
(right). Scale bar: 10 μm. 
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interactions (i.e., through addition of rRNA to protein droplets and manipulating 
electrostatic interactions) affected protein dynamics within the droplets. To do this, we 
performed a series of fluorescent recovery after photobleaching (FRAP) microscopy 
experiments. FRAP reports on the rate at which proteins diffuse within the droplets, as 
well as the fraction of the protein molecules that are able to diffuse within the droplet 
(i.e., mobile fraction).   
 
We began by testing the effects of varying salt concentration, and thus 
electrostatic interactions, on protein dynamics. We wanted to modulate the valency of the 
system, so we chose to use SURF6 for these experiments as this R-protein has the largest 
number of R-motifs, and thus the largest number of possible NPM1 binding sites (Figure 
3-5a). Droplets were made with only one labeled protein at a time to prevent fluorescence 
resonance energy transfer (FRET) between the two fluorophores (Alexa Fluor488 for 
NPM1 and Alexa Fluor555 for SURF6) at a 1:1 ratio at 5, 10, and 20 μM. Droplets were 
then imaged by confocal microscopy thirty minutes after mixing (Figure 3-7). Only large 
droplets made at 20 μM protein were photobleached as these droplets at higher NaCl 
concentrations were still large enough for FRAP experiments. Regions of roughly 0.67 
μm2 at the center of the droplet were photobleached and FRAP was monitored until 
recovery curves plateaued. Although LLPS was observed at 150 and 175 mM NaCl, the 
observed droplets were too small to obtain accurate FRAP measurements as the bleached 
region would occupy most of the droplet. At 200 mM NaCl, droplets no longer formed. 
As expected, when the NaCl concentration was increased, SURF6 mobility increased 
from 80.3% to 98.0 % (p < 0.001) and the apparent rate of diffusion increased from 
approximately 0.01 μm2/s to 0.06 μm2/s (p < 0.001) (Figure 3-8). However, for N294, 
only the apparent rate of diffusion increased with NaCl concentrations with an average 
from 0.02 μm2/s to 0.03 μm2/s (p = 0.001), whereas the percent mobile fraction decreased 
on average from 89.4% to 76.7% (p = 0.001) as the NaCl concentration increased from 
75 mM to 125 mM (Figure 3-9).  
 
After analyzing the effects of electrostatic interactions on N294 droplets, we next 
determined how rRNA affects protein dynamics within droplets. We already knew from 
the R-peptides and R-protein droplet experiments discussed above that rRNA can interact 
with and phase separate with R-motifs. However, when examining the phase separation 
behavior of rRNA with R-motif-containing peptides or proteins, we observed either 
smaller puncta or smaller droplets with R-peptides and R-proteins, respectively. This led 
us to believe that protein/protein interactions differ from protein-rRNA interactions and 
that we can therefore also modulate protein dynamics by altering protein and rRNA 
concentrations within the droplets. To test this hypothesis, we utilized one of the R-
proteins that was able to phase separate with N294, but did not form droplets that readily 
fused with one another, GNL2 (Figure 3-5). Following the same protocol for FRAP 
experiments described above, we analyzed droplets composed of N294/rRNA, 
N294/GNL2, and N294/GNL2/rRNA. Droplets composed of only N294 and rRNA were 
round and fused readily, whereas droplets composed of N294 and GNL2, although round, 
did not fuse with one another but rather docked on each other much like beads on a string 
(Figure 3-10a). This “beads on a string” appearance was diminished when rRNA was 
incorporated into the droplets (Figure 3-10a). A488-N294 and A555-GNL2 were then 
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Figure 3-7. Salt Dependence of Surf6/N294 Droplets 
Confocal images of N294/SURF6 mixtures at various salt concentrations. Images were 
acquired 15 minutes after mixing. Scale Bar: 5 μm 
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Figure 3-8. Effects of Electrostatic Interactions of Surf6 Dynamics within 
N294/Surf6 Droplets  
A. FRAP curve fit to a single exponential. B. Mobile fraction of Surf6 calculated from 
the FRAP curve fit to a single exponential. C. Apparent rate of diffusion calculated from 
the recovery timescale, τ, and the bleached radius. *** p < 0.001, ** p < 0.01, * p < 0.05, 
n.s. not significant.        
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Figure 3-9. Effects of Electrostatic Interactions of N294 Dynamics within 
N294/Surf6 Droplets  
A. FRAP curve fit to a single exponential. B. Mobile fraction of Surf6 calculated from 
the FRAP curve fit to a single exponential. C. Apparent rate of diffusion calculated from 
the recovery timescale, τ, and the bleached radius. *** p < 0.001, ** p < 0.01, * p < 0.05, 
n.s. not significant.       
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Figure 3-10. NPM1/GNL2 Droplets Can Be Modulated by the Addition of rRNA 
A. 10 μM N294 (spiked with 1 μM Alexa Fluor488 N294) mixed with 50 μg/mL wheat 
germ rRNA (left), 20 μM GNL2 (middle), and the tertiary mixture. Images were acquired 
2.5 hours after mixing. Scale bar: 5 μm. B. Graphs comparing the differences in N294 
(green) and GNL2 (pink) mobile fraction (left) and diffusion coefficients (right) acquired 
from FRAP data. N=10. *** p < 0.001, ** p < 0.01, * p < 0.05, n.s. not significant.     
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photobleached, separately, to obtain FRAP curves from which protein mobility and 
diffusion rates were calculated. N294 mobility only increased slightly and when GNL2 
was incorporated into the droplets when compared to N294/rRNA droplets (p=0.0464), 
whereas the addition of rRNA to N294/GNL2 droplets had no effect on N294 mobility or 
the rate of diffusion (Figure 3-10b). N294 diffusion was drastically slower (0.004±0.02 
μm2/s versus 0.03±0.12 μm2/s, p=0.0024) when GNL2 was incorporated into droplets 
than in N294/rRNA droplets alone (Figure 3-10b). Addition of rRNA to droplets, 
however, had a more drastic effect on GNL2 mobility and diffusion; GNL2 mobility 
increased from 40.8±6.2% to 77.8±5.1% (p<0.0001), and GNL2 diffusion increased from 
0.001±0.0002 μm2/s to 0.006±.004 μm2/s (p=0.0009) when rRNA was a part of the 
droplet network (Figure 3-10b). 
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CHAPTER 4.    DISCUSSION 
 
 
 Eukaryotic cells harbor both membrane-bound and membrane-less organelles. 
Unlike the classical membrane-bound organelles, membrane-less organelles lack a 
tangible barrier separating their components from the nucleo- or cytoplasm. Despite the 
knowledge of their existence for more than a century, their assembly, function, and 
maintenance are still poorly understood. It has recently become widely accepted that this 
class of organelles arise through LLPS of their components creating a fluid environment 
within them (Brangwynne, et. al. 2011; Feric, et. al., 2016; Guo and Shorter, 2015; Han, 
et. al., 2012; Mitrea, et. al., 2016; Molliex, et. al, 2015; Nott, et. al., 2015; Weber and 
Brangwynne, 2015). The largest membrane-less organelle, the nucleolus, is located in the 
nucleoplasm and is the site of ribosome biogenesis and a sensor for cellular stress 
(Tafforeau, et. al., 2013). Despite the lack of a lipid membrane, nucleoli are organized 
into three compartments: the fibrillar center (FC), the dense fibrillar component (DFC), 
and the granular component (GC). Of these compartments, the GC (Brangwynne, et. al., 
2011) and, more recently, the DFC (Feric, et. al., 2016) have been shown to exhibit 
liquid-like properties. Nucleophosmin 1 (NPM1) is highly enriched in the GC and 
exhibits structural features found to promote LLPS, specifically multivalent acidic tracts, 
a nucleic acid binding domain, and a disordered region (Elbaum-Garfinkle, et. al., 2015; 
Li, et. al., 2012; Molliex et. al., 2015). It has previously been shown that the acidic tracts 
of NPM1 interact with R-rich motifs (Mitrea, et. al., 2014) and the CTD can bind to 
rRNA (Wang, et. al., 1994). Based on these previous observations, we hypothesized that 
NPM1 can undergo LLPS with its nucleolar binding partners (i.e., rRNA and R-rich 
proteins), thus creating a heterogeneous network of weak and transient interactions that 
contribute to the liquid-like behavior of nucleoli. 
 
Here, we showed that multivalent R-motifs are enriched in NPM1 binding 
partners, many of which are also nucleolar proteins. We have shown that weak, 
electrostatic interactions between NPM1 and R-rich motifs promote LLPS in vitro, and 
that phase separation is dependent on multivalency, protein concentration, and buffer 
ionic strength. Furthermore, we showed how droplet morphology was modulated by 
altering the spacing between R-motifs, changing buffer ionic strength, and incorporating 
rRNA in the droplets. Using microscopic techniques, we then showed how protein 
dynamics within droplets changes in response to changes in ionic strength and when 
rRNA is added to the droplets. 
 
 
NPM1 Interacts with a Variety of Arginine-Rich Motif Nucleolar Proteins through 
Weak, Electrostatic Interactions  
 
Through the analysis of a list of NPM1 binding partners, we discovered that the 
majority of NPM1 binding partners are enriched in multivalent R-motifs, compared to the 
majority of proteins in the human proteome (p<0.0001), and that many of these proteins 
are known to localize to the nucleolus. These results suggested that the presence of 
multivalent R-motifs is sufficient for proteins to, i) bind to NPM1 and ii) localize within 
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the nucleolus. In order to promote phase separation but also maintain a liquid-like 
environment, interactions must be strong enough to form larger molecular assemblies, but 
also weak enough to allow proteins to remain dynamic (Li, et. al., 2012). Previous work 
published by the Kriwacki lab showed that R-rich motifs bind to at least two of the three 
acidic tracts (A1 and A2) within NPM1 (Mitrea, et. al., 2014), and here we showed that 
R-motif peptides bind to NPM1 with low micromolar dissociation constants. 
Furthermore, the binding affinities decreased when the valency of the R-peptide was 
decreased. Additionally, for the RPL5 peptides, the presence of a second R-motif not 
only increased the affinity for NPM1 but also increased the total amount that bound to 
N130; for example, more of the wild type RPL5 peptide bound to N130 than the RPL5-
RA mutant. Furthermore, when peptides containing more than two R-motifs (RPL23a47-
68) or more extensive R-motifs (GNL2682-709) were titrated into N130, the ITC data 
appeared to exhibit multiple binding events, suggesting that the different R-motifs could 
bind to N130 but with different affinities. These observations led us to hypothesize that 
that weak, electrostatic interactions between multivalent R-motifs and NPM1 would 
promote LLPS, as seen by others with other proteins (Banajade and Rosen, 2016; Li, et. 
al., 2012; Su, et. al., 2016). 
 
 
Weak, Multivalent Electrostatic Interactions Promote In Vitro Phase Separation 
  
We next sought to test the hypothesis that weak, electrostatic interactions between 
multivalent R-motifs and NPM1 acidic tracts causes LLPS. We initially proved, using a 
minimalistic system, that multivalent interactions between R-motifs and NPM1 acidic 
tracts do promote LLPS in vitro, as observed by microscopy, and that the observed phase 
transition was dependent on a highly multivalent system (i.e., at least two R-motifs per 
peptide and two acidic per NPM1 monomer), as observed by changes in turbidity 
(Mitrea, et. al., 2016). Additionally, each of the peptides were able to form liquid-like 
droplets that fused with one another and grew over time, however the threshold for phase 
separation and size of the droplets varied among peptides. The peptide with the lowest R-
motif valency (e.g., with the smallest number of R-motifs and smallest total number of 
arginine residues within them), RPL521-37, exhibited the highest LLPS concentration 
threshold, meaning higher concentrations of N130 and RPL521-37 were required to 
promote LLPS. GNL2682-709 and SURF6299-326 exhibited much lower concentration 
thresholds and were able to form droplets with as little as 5 μM N130, most likely due to 
more arginine residues within their R-motifs. Even though each of these peptides 
experienced different concentration thresholds, droplet formation would not occur unless 
excess peptide was present as, according to our definition, these peptides only had two R-
motifs. One the other hand, RPL23a47-68, which contains three R-motifs that could 
potentially bind to N130, was able to phase separate with N130 at low concentrations 
(Figure 3-2) and at a 1:1 ratio of N130 to peptide. Additionally, these droplets appeared 
larger in size and were more abundant than droplets formed from the other peptides. To 
further understand how sequence features can dictate droplet size, we analyzed two 
additional RPL5-like peptides that were engineered to have longer linkers (comprised 
mostly of Gly-Ser repeats) between the two R-motifs. Interestingly, increasing the linker 
length was associated with increases droplet size (Figure 3-3). The results of these 
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experiments show that increasing the valency of the system decreases the phase 
separation threshold to lower concentrations and NPM1:R-motif peptide molar ratios, just 
as has reported by others for other systems (Li, et. al., 2012). Furthermore, these results 
suggest that differences in valency (i.e., the number of R-motifs) and distance between 
these R-motifs among various R-rich nucleolar NPM1 binding partners are associated 
with varied propensities to undergo LLPS with NPM1 and possibly to heterogeneity of 
the fluid properties within the GC region of nucleoli.   
 
The observation that NPM1 is not required for ribosome biogenesis (Amin, et. al., 
2008; Holmberg, et. al., 2014) suggested that the liquid-like features of the GC region of 
the nucleolus may arise through phase separation of nucleolar components apart from 
NPM1. To test this idea, we determined whether interactions between proteins with 
multivalent R-motifs and rRNA caused LLPS. Using the same peptides as with N130 and 
wheat germ rRNA, we titrated increasing amounts of peptide into rRNA, and vice versa, 
and measured changes in turbidity. We observed that increases turbidity during these 
titration and then used microscopy to determine whether droplets formed because 
turbidity only indicates a change in particle size and/or number, not particle shape and 
fluidity. Using microscopy, we observed that instead of droplets, as with N130, R-
peptides and rRNA phase separated into small puncta (~1 μm in diameter) that did not 
fuse. Interestingly, even though NPM1 is not required for ribosome biogenesis, without 
NPM1, the GC of nucleoli do not assemble properly and appear distorted (Amin, et. al., 
2008). Altogether, these data suggest that NPM1 plays a role in mediating LLPS by 
acting as a scaffold to which R-rich proteins can form crosslinks with the A-tracts within 
NPM1 pentamers. Furthermore, as R-peptides and rRNA alone and N122 and peptides 
alone could not form liquid-like droplets, we hypothesize that droplet formation requires 
the high multivalency associated with A-tracts within pentameric N130. 
 
 
NPM1 Phase Separates with Nucleolar Arginine-Rich Motif Containing Proteins 
and rRNA to Form Liquid-Like In Vitro Droplets 
 
Moving beyond our minimalistic system with peptides and truncated NPM1, we 
began screening for droplet formation using a more physiologically relevant and complex 
system using full-length NPM1 (N294) and nucleolar R-protein constructs identified as 
NPM1 binding partners (SURF61-182, GNL2630-731, RPL23a1-156, and Nucleolin610-709). 
SURF6 is a known nucleolar protein, disordered, and important for ribosome biogenesis 
(Magoulas, et. al., 1998; Romanova, et. al., 2006). A specific function for SURF6 has not 
yet been determined, but it is quite possible that SURF6 functions as a disordered 
nucleolar matrix protein to contribute to the liquid-like properties of nucleoli. GNL2 is a 
nucleolar GTPase required for release of pre-60S ribosomal particles from the nucleolus 
and contains disordered N- and C-terminal regions harboring multivalent R-motifs 
(Matsuo, et. al., 2014). RPL23a is a large ribosomal subunit protein required for 
intermediate pre-rRNA processing steps, and contains a disordered N-terminal region 
containing R-motifs (Gamalinda, et. al., 2014). Nucleolin is a multifunctional nucleolar 
protein with features similar to those of NPM1. Specifically, nucleolin has a disordered 
N-terminal region containing multiple acidic tracts, a folded central region with multiple 
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RNA binding domains, and a disordered C-terminal region containing stretches of 
glycine/arginine repeats known as GAR domains (Tajrishi, et. al., 2011). Each of these 
proteins plays distinct roles within the nucleolus and therefore may contribute differently 
to the liquid-like nucleolar environment. 
 
Using confocal microscopy as with our minimalistic system, we showed that each 
of the R-proteins phase separated with N294. However, to our surprise, not all R-proteins 
phase separated with N294 to form liquid-like droplets as did the peptides. SURF6 and 
RPL23a formed highly “fuse-able” droplets, while GNL2 formed less fluid droplets that 
did not readily fuse with each other. Additionally, nucleolin and NPM1 phase separated 
into a solid-like state rather than a liquid-droplet state. Thus, we propose that a hierarchy 
of R-motifs, exhibiting a range of affinities for NPM1, exists within nucleolar proteins, 
which leads to a heterogeneous network of interactions with NPM1 within droplets and 
possibly the nucleolus.  
 
NPM1 also contains a C-terminal nucleic acid binding domain that has been 
shown to interact with rRNA (Wang, et. al., 1994). Here, we have shown that these 
interactions cause phase separation to form liquid-like droplets that fuse over time. 
Additionally, we have shown that nucleolin, which also contains RNA binding domains 
(i.e., structured RRM domains and disordered GAR domains), can be incorporated into 
N294/rRNA droplets even though nucleolin and N294 did not form droplets in the 
absence of rRNA. Nucleolin and NPM1 both exhibit acidic tracts and can bind to rRNA; 
however, nucleolin is not known to self-oligomerize. It is possible that, under conditions 
other than those tested here, nucleolin does phase separate with rRNA or R-motif proteins 
in the absence of NPM1; however, if oligomerization is required to create a highly 
multivalent scaffold as seen with NPM1 (Mitrea, et. al., 2016), LLPS with nucleolin may 
not be possible. Additional experiments will be needed, however, to determine if 
nucleolin and rRNA, and nucleolin and R-proteins, undergo LLPS without NPM1. 
Additionally, unlike our results with short R-motif containing peptides, not all R-proteins 
required NPM1 to undergo LLPS with rRNA, as shown by the observations that SURF6 
and rRNA phase separated to form liquid-like droplets in the absence of NPM1. Unlike 
the short peptides, SURF6 is highly multivalent with six R-motifs within the N-terminal 
region of the protein that can potentially interact with rRNA. This suggests that the R-
motifs are spaced sufficiently far apart to create the crosslinks between rRNA molecules 
required to maintain a liquid-like phase. In the future, experiments using a series of 
SURF6 constructs in which varied numbers of R-motifs are mutated to alter rRNA 
binding will need to be performed to test this hypothesis. Overall, these data suggest that 
NPM1, R-proteins, and rRNA form a network of multivalent interactions that promote 
LLPS and, thus, a dynamic liquid-like phase in nucleoli. Thus, altering R-protein 
concentration, valency, and affinity could provide a means to tune the fluid environment 
of droplets and, presumably, nucleoli (i.e., viscosity, surface tension and protein 
dynamics). 
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Protein Dynamics within Droplets Can Be Modulated by Electrostatic Interactions 
 
 We have shown that LLPS of NPM1 with R-proteins arises from a network of 
weak, electrostatic interactions between oppositely charged A-tracts and R-motifs, 
respectively, and that droplet morphology differs between constructs with varying 
degrees of valency. Therefore, we wanted to determine how changing valency alters 
protein dynamics within the liquid-like droplets. SURF6 exhibits the largest number of 
R-motifs, six in total, and was thus used in experiments in which ionic strength was 
varied to modulate multivalency for binding to NPM1. As expected, when the NaCl 
concentrations was increased, droplet size decreased and eventually, at 200 mM NaCl, 
the electrostatic interactions required for droplet formation were disrupted. Interestingly, 
by monitoring FRAP, we observed different dynamics for NPM1 and SURF6 as a 
function of NaCl concentration. Specifically, as expected, when the NaCl concentration 
was increased, the mobile fraction (i.e., amount of protein able to move throughout the 
droplet) of SURF6 also increased.  Additionally, this increase in mobile SURF6 was 
accompanied with an increase in the rate of SURF6 diffusion. More simply, the 
disruption of electrostatic interactions between NPM1 and SURF6 liberated more 
SURF6, and, since diffusion rates are inversely proportional to the particle size, this 
suggests that the avidity of interactions between SURF6 and NPM1 was reduced. NPM1, 
on the other hand, did not behave similarly. With NPM1, increasing the NaCl 
concentration actually decreased the amount of mobile NPM1 and only slightly increased 
the rate at which NPM1 diffused within droplets. Although these results seem 
contradictory, it is possible that at a lower salt concentration, NPM1 pentamers may 
become more compact, blocking the weaker acidic tract (A3) by the basic C-terminal 
region and therefore promoting the stronger interactions with A1 and A2 with each 
SURF6 R-motif. Recent, unpublished data suggests an autoinhibitory mechanism within 
NPM1 where the basic CTD blocks A-tracts via homotypic intra- and inter-molecular 
interaction (Mitrea, Cika & Kriwacki, unpublished). Likewise, as salt concentrations are 
increased, electrostatic interactions between NPM1 and SURF6, as well as NPM1 with 
itself, are disrupted, and therefore the network within the droplet and NPM1 opens up, 
becoming less compact, and exposing the weaker A3 (Figure 4-1). Now there is more 
room and more available acidic tracts for NPM1 to participate in crosslinking with 
SURF6, however with less R-motifs, so droplets therefore decrease in size as valency 
decreases. To test this hypothesis, salt titrations using an NPM1 construct lacking the 
basic C-terminal region and thus an available A3 at all salt concentrations need to 
preformed and compared to wild type NPM1. 
 
 
Protein Dynamics within Droplets Can Be Modulated by rRNA 
 
 Nucleoli are the site for ribosome biogenesis, and thus contain large amounts of 
rRNA. We next examined how rRNA affects protein dynamics within droplets. In order 
to keep the system as simple as possible while still allowing each component to interact 
with one another, we analyzed droplets composed of N294 (containing the rRNA binding 
CTD), GNL2 (containing only one multivalent R-motif that can interact with both NPM1 
and rRNA, but only forms droplets with NPM1), and rRNA. Droplets comprised of all  
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Figure 4-1. NPM1 Droplet Network Can Be Tuned by Modulating Electrostatic 
Interactions 
Low salt conditions (left) increases electrostatic interactions and promotes a more 
compact NPM1 conformation. NPM1 CTD (pink) blocks acidic tracts (red), preventing 
R-motifs (blue) from forming additional crosslinks. Increasing salt concentrations 
disrupts electrostatic interactions (right) promotes a less compact NPM1 conformation 
and droplet network, giving R-motifs access to additional acidic tracts.  
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three components readily fused with one another, whereas droplets comprised of only 
N294 and GNL2 did not exhibit fusion. The increased fluidity of ternary droplets was 
accompanied by an increase in the fraction of GNL2 that was mobile and the rate at 
which it diffused within droplets, in comparison with the behavior of GLN2 within binary 
droplets with just NPM1. The fraction of mobile NPM1, on the other hand, was similar in 
binary droplets comprised of N294 and rRNA, and N294 and GNL2, and increased only 
slightly in ternary droplets (Figure 3-10). Furthermore, NPM1 diffusion decreased when 
GNL2 was incorporated into droplets. Although the fraction of mobile NPM1 was 
slightly increased when both GNL2 and rRNA were present, NPM1 exhibited a reduced 
diffusion rate. This could be due to, in the ternary droplet, rRNA competing with NPM1 
for GNL2 thus disrupting rRNA and GNL2 crosslinks between pentamers and slightly 
increasing the mobile fraction of NPM1. However, here GNL2 is also present which also 
binds to the freely diffusing NPM1 fraction, thus reducing the rate of NPM1 diffusion. 
When all three components are present, crosslinks are formed between NPM1 and both 
rRNA and GNL2, which in turn frees GNL2 from NPM1 and increases GNL2 mobility 
and its rate of diffusion (Figure 4-2).  To further understand the nature of the network 
making up the ternary droplets it would be informative to have labeled rRNA in order to 
monitor changes in rRNA dynamics with and without GNL2. 
 
These data show how NPM1 binding partners, especially those known to reside 
within the nucleolus, are enriched in multivalent R-motifs, which suggests a common 
mechanism for nucleolar localization of proteins. These proteins, through their R-motifs, 
are able to interact weakly and transiently through electrostatic interactions with the 
multivalent acidic tracts within NPM1. Furthermore, these multivalent interactions 
promote LLPS in vitro, suggesting an explanation for the liquid-like behavior of nucleoli 
(Brangwynne, et. al., 2011; Feric, et. al., 2016). Furthermore, the properties of the liquid-
like phase of NPM1-containing droplets can be manipulated by altering R-motif valency, 
the number of amino acids between R-motifs, and electrostatic interactions, and through 
the incorporation of rRNA. These preliminary data provide additional insight into the 
biophysical properties and molecular mechanisms governing phase separation and, thus, 
expand our understanding of membrane-less organelle formation and function.   
 
 
Future Directions 
 
Although these results offer a deeper understanding for LLPS and membrane-less 
organelles, there is still much work to be done to be able to connect molecular properties 
(i.e., sequence features and protein structure) to biological functions (i.e., processes 
associated with RNA metabolism, ribosome biogenesis, stress responses, etc.). To gain a 
more clear understanding of LLPS and nucleolar structure and function, additional 
experiments are needed to measure other biophysical properties of in vitro droplets (i.e., 
viscosity and surface tension). Others have begun to study changes in these parameters 
using in vitro systems pertaining to nucleoli and P granules (Elbaum-Garfinkle, et. al., 
2015; Feric, et. al., 2016). We have suggested that SURF6, and other similar nucleolar 
proteins (i.e., exhibit disordered regions enriched in multivalent R-motifs but have no 
known function), may mainly modulate the liquid-like nature of nucleolar matrix. To gain  
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Figure 4-2. Protein Dynamics Can Be Tuned by the Addition of rRNA  
Droplets consisting of NPM1 and R-proteins form a more extensive network resulting in 
a dense liquid-like phase. The addition of rRNA (black) disrupts some of the crosslinks 
by competing for R-proteins with NPM1. This results in a less dense liquid-like phase 
and increases R-protein dynamics within droplets and droplet fluidity.  
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further insight into the roles these proteins play and the effect of their R-motif valency 
and linker length between R-motifs, a series of R-protein mutants where individual R-
motifs are mutated should be studied (i.e., measuring protein dynamics within droplets 
and, potentially, droplet viscosity and surface tension) and compared to the wild-type 
proteins as discussed here. These experiments will give insight into the types of 
interactions between NPM1 and R-proteins which promote LLPS and how to modulate 
droplet properties by altering the network of interactions making up the liquid-like phase. 
For the R-protein mutants that alter droplet material properties, we can then incorporate 
these mutant proteins into live cells to test if these molecular changes cause a biological 
response. In cells transfected with the mutant R-proteins, FRAP experiments in live cells 
monitoring other nucleolar proteins, for instance NPM1, would allow us to measure 
changes in NPM1 nucleolar diffusion in response to changes in valency of nucleolar 
matrix proteins. We would also analyze nucleolar size, shape, and number in order to 
relate changes in the structure of the nucleolar matrix to changes in nucleolar integrity. 
rRNA processing, an aspect of ribosome biogenesis, could be monitored using 
radioactively labeled methionine to label  newly transcribed rRNA (Olausson, et. al., 
2014). Together, these experiments will give novel insight into the types of interactions 
that make up nucleoli and promote the observed liquid-like behavior; furthermore, these 
experiments will allow us to relate the biophysical properties observed with in vitro 
droplets to the molecular properties and functional roles of nucleoli.  
 
 
Broader Implications 
 
 It is believed that membrane-less organelles, including nucleoli, arise through 
LLPS of their components. However, the underlying molecular mechanisms governing 
phase separation are currently not clearly understood. By studying the biophysical 
properties governing LLPS with NPM1 in vitro, we can gain insight into the molecular 
mechanisms governing LLPS in vivo. Furthermore, this knowledge provides a molecular 
explanation for the localization of nucleolar proteins through LLPS via multivalent 
interactions between acidic tracts (in NPM1) and R-motifs (in R-proteins). Many 
disordered nucleolar proteins contain patches of acidic residues or R-motifs, but their 
function within the nucleolus is unknown. Our results with NPM1 and R-proteins suggest 
a potential nucleolar role for these proteins, as nucleolar matrix proteins that promote a 
liquid-like environment.  
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APPENDIX A. PROTEIN PURIFICATION 
 
 
Table A-1. Protein Sequences 
 
Construct Sequence 
N130 GSWEDSMDMDMSPLRPQNYLFGCELKADKDYHFKVDNDENE
HQLSLRTVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLKMS
VQPTVSLGGFEITPPVVL 
RLKCGSGPVHISGQHLVAVEEDAESEDEEE 
N294 GSHMEDSMDMDMSPLRPQNYLFGCELKADKDYHFKVDNDEN
EHQLSLRTVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLKM
SVQPTVSLGGFEITPPVVLRLKCGSGPVHISGQHLVAVEEDAESE
DEEEEDVKLLSISGKRSAPGGGSKVPQKKVKLAADEDDDDDDE
EDDDEDDDDDDFDDEEAEEKAPVKKSIRDTPAKNAQKSNQNG
KDSKPSSTPRSKGQESFKKQEKTPKTPKGPSSVEDIKAKMQASIE
KGGSLPKVEAKFINYVKNCFRMTDQEAIQDLWQWRKSL 
RPL23a GSHMAPKAKKEAPAPPKAEAKAKALKAKKAVLKGVHSHKKK
KIRTSPTFRRPKTLRLRRQPKYPRKSAPRRNKLDHYAIIKFPLTTE
SAMKKIEDNNTLVFIVDVKANKHQIKQAVKKLYDIDVAKVNTL
IRPDGEKKAYVRLAPDYDALDVANKIGII 
GNL2 GSHEKIFAKPEEQRKTLEEDVDDRAPSKKGKKRKAQREEEQEH
SNKAPRALTSKERRRAVRQQRPKKVGVRYYETHNVKNRNRNK
KKTNDSEGQKHKRKKFRQKQ 
Nucleolin GSHKGFGFVDFNSEEDAKAAKEAMEDGEIDGNKVTLDWAKPK
GEGGFGGRGGGRGGFGGRGGGRGGRGGFGGRGRGGFGGRGG
FGGRGGGGDH KPQGKKTKF 
SURF6 GSHMASLLAKDAYLQSLAKKICSHSAPEQQARTRAGKTQGSET
AGPPKKKRKKTQKKFRKREEKAAEHKAKSLGEKSPAASGARRP
EAAKEEAAWASSSAGNPADGLATEPESVFALDVLRQRLHEKIQ
EARGQGSAKELSPAALEKRRRRKQERDRKKRKRKELRAKEKA
RKAEEATEAQEVVE 
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Figure A-1. RPL23a Protein Purification 
A. Chromatogram from 6xHis-RPL23a purification by Ni-NTA affinity chromatography. 
RPL23a-containing fractions are labeled with as asterisk. B. SDS-PAGE gel of protein-
containing fractions eluted from Ni-NTA column. C. Chromatogram from RPL23a 
purification by HPLC. RPL23a-containing fractions are labeled with as asterisk. D. SDS-
PAGE gel of protein-containing fractions eluted from HPLC. Courtesy of Cheon-Gil 
Park. 
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Figure A-2. Nucleolin Protein Purification 
A. Chromatogram from 6xHis-Nucleolin purification by Ni-NTA affinity 
chromatography. Nucleolin-containing fractions are labeled with as asterisk. B. SDS-
PAGE gel of protein-containing fractions eluted from Ni-NTA column. C. 
Chromatogram from Nucleolin purification by HPLC. RPL23a-containing fractions are 
labeled with as asterisk. D. SDS-PAGE gel of protein-containing fractions eluted from 
HPLC. Courtesy of Cheon-Gil Park and Dr. Mylene Ferrolino. 
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Figure A-3. GNL2 Protein Purification 
A. Chromatogram from 6xHis-GNL2 purification by Ni-NTA affinity chromatography. 
GNL2-containing fractions are labeled with as asterisk. B. SDS-PAGE gel of protein-
containing fractions eluted from Ni-NTA column. C. Chromatogram from GNL2 
purification by HPLC. GNL2-containing fractions are labeled with as asterisk. D. SDS-
PAGE gel of protein-containing fractions eluted from HPLC. Courtesy of Cheon-Gil Park 
and Dr. Mylene Ferrolino. 
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Figure A-4. SURF6 Protein Purification 
A. Chromatogram from 6xHis-SURF6 purification by Ni-NTA affinity chromatography. 
SURF6-containing fractions are labeled with as asterisk. B. SDS-PAGE gel of protein-
containing fractions eluted from Ni-NTA column. C. Chromatogram from SURF6 
purification by HPLC. SURF6-containing fractions are labeled with as asterisk. D. SDS-
PAGE gel of protein-containing fractions eluted from HPLC. 
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APPENDIX B. PROTEIN CHARACTERIZATION 
 
 
 
 
Figure B-1. RPL23a Structure Characterization 
A. Purified RPL23a was refolded against 150 mM NaCl buffer. Proper refolding was 
confirmed by CD. RPL23a contains both β-sheet and helix structure as well as a 
disordered tail which was confirmed by peaks at ~225 nm and 205 nm, respectively. B. 
Crystal structure of RPL23a within the human 60S ribosomal subunit. (PDB ID 4V6X 
chain CX.) 
 
 
 
 
 
 
Figure B-2. CD Spectra of Purified R-Proteins 
CD spectra of R-proteins in were collected and were buffer subtracted. SURF6 and 
Nucleoin appear to have some structured elements, but all of the proteins contain the 
predicted disordered elements. 
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Table B-1. Protein Molecular Weight and Extinction Coefficients 
 
Construct Molecular Weight 
(KDa) 
Extinction Coefficient 
(M-1 cm-1) 
RPL23a47-68 2.8 1,280 
GNL2682-709 3.6 2,560 
SURF6299-326 3.7 5,690 
RPL521-37 2.2 2,560 
RPL5-RA 2.1 2,560 
RPL5-20L 2.9 2,560 
RPL5-16L 2.6 2,560 
N130 14.6 9,530 
N122 13.6 3,840 
N294 32.6 16,500 
SURF61-182 20.2 6,970 
GNL2630-731 12.7 2,560 
RPL23a1-156 18.0 6,400 
Nucleolin610-709 10.4 5,690 
 
Molecular weights and extinction coefficients were calculated using the Scripps Protein 
Calculator freely available online (http://protcalc.sourceforge.net/).  
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